SCHEMBL30790695

SCHEMBL30790695

O=C1c2ccccc2C(=O)N1[C@H]1CC[C@@H](Oc2cc(N3CCOCC3)cc3nccnc23)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 2/20 0.36
DCLK1 O15075 1/20 0.36
MAPK7 Q13164 1/20 0.36
BMPR1B O00238 1/20 0.36
PDGFRB P09619 1/20 0.36
KIT P10721 1/20 0.36
PDGFRA P16234 1/20 0.36
BMPR1A P36894 1/20 0.36
ACVR1B P36896 1/20 0.36
TGFBR1 P36897 1/20 0.36
ACVRL1 P37023 1/20 0.36
ACVR1 Q04771 1/20 0.36
SYK P43405 3/20 0.36
KIF11 P52732 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
ALDH1A1 P00352 2/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
TTK P33981 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16039402 1.00 LRRK2 (0.36) LRRK2DCLK1MAPK7BMPR1BPDGFRB
SCHEMBL16039400 1.00 LRRK2 (0.36) LRRK2DCLK1MAPK7BMPR1BPDGFRB
SCHEMBL16041807 0.86 ADRA1D (0.33) L3MBTL1ALDH1A1GAAADRA1DADRA1A
SCHEMBL16088308 0.86 ADRA1D (0.33) L3MBTL1ALDH1A1GAAADRA1DADRA1A
SCHEMBL21187331 0.83 MEN1 (0.38) LRRK2DCLK1MAPK7ALDH1A1MEN1
SCHEMBL30823285 0.83 MEN1 (0.38) LRRK2DCLK1MAPK7ALDH1A1MEN1
SCHEMBL21178069 0.83 MEN1 (0.38) LRRK2DCLK1MAPK7ALDH1A1MEN1
SCHEMBL30817826 0.82 ALDH1A1 (0.40) LRRK2DCLK1MAPK7SYKKIF11
SCHEMBL21187359 0.82 ALDH1A1 (0.40) LRRK2DCLK1MAPK7SYKKIF11
SCHEMBL28471532 0.82 ALDH1A1 (0.40) LRRK2DCLK1MAPK7SYKKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111741955-B DNA-PK inhibitors 沃泰克斯药物股份有限公司 2024-02-23 CN disclosed